Evidence map›Paper›PMID 35205374›Full record

ArticleGenes2022

Impact of Variants in the

Karla Beatriz Cardias Cereja Pantoja, Tereza Cristina de Brito Azevedo, Darlen Cardoso de Carvalho, Natasha Monte, Amanda de Nazaré Cohen Paes, Maria Clara da Costa Barros, Lui Wallacy Morikawa Souza Vinagre, Ana Rosa Sales de Freitas, Rommel Mario Rodríguez Burbano, Paulo Pimentel de Assumpção and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Karla Beatriz Cardias Cereja PantojaNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém 66073-005, PA, Brazil.ORCID 0000-0002-1278-3722
Tereza Cristina de Brito AzevedoHospital Ophir Loyola, Belém 66063-240, PA, Brazil.ORCID 0000-0002-9352-326X
Darlen Cardoso de CarvalhoNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém 66073-005, PA, Brazil.ORCID 0000-0002-2716-860X
Natasha MonteNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém 66073-005, PA, Brazil.ORCID 0000-0003-4061-5045
Amanda de Nazaré Cohen PaesNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém 66073-005, PA, Brazil.ORCID 0000-0003-3548-292X
Maria Clara da Costa BarrosLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66077-830, PA, Brazil.ORCID 0000-0002-5886-4069
Lui Wallacy Morikawa Souza VinagreNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém 66073-005, PA, Brazil.ORCID 0000-0002-7063-6149
Ana Rosa Sales de FreitasNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém 66073-005, PA, Brazil.
Rommel Mario Rodríguez BurbanoHospital Ophir Loyola, Belém 66063-240, PA, Brazil.ORCID 0000-0002-4872-234X
Paulo Pimentel de AssumpçãoNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém 66073-005, PA, Brazil.ORCID 0000-0003-3846-8445
Sidney Emanuel Batista Dos SantosLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66077-830, PA, Brazil.ORCID 0000-0002-8622-9417
Marianne Rodrigues FernandesNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém 66073-005, PA, Brazil.ORCID 0000-0002-1396-3442
Ney Pereira Carneiro Dos SantosNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém 66073-005, PA, Brazil.ORCID 0000-0001-8087-7037
Universidade Federal do Pará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm derived from the balanced reciprocal translocation of chromosomes 9 and 22 t (9q34 and 22q11), which leads to the formation of the Philadelphia chromosome and fusion of the

Indexed as

BenzamidesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDNA-Binding ProteinsDrug Resistance, NeoplasmHumansHydroxymethyl and Formyl TransferasesImatinib MesylateMultienzyme ComplexesNucleotide DeaminasesPiperazinesPyrimidinesTranscription FactorsTranslocation, GeneticARID5B protein, humanBenzamidesDNA-Binding ProteinsHydroxymethyl and Formyl TransferasesImatinib Mesylateinosine monophosphate synthaseMultienzyme ComplexesNucleotide DeaminasesPiperazinesPyrimidinesTranscription FactorsARIDB5 geneATIC genechronic myeloid leukemiaimatinibpharmacogenomics

Identifiers

PMID35205374
PMCPMC8872593
OpenAlexW4211151186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.